Dr. Sidan Li 李斯丹
Chief Physician, Associate Professor
Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical treatment of common malignancies, with a focus on lymphoma, hematologic tumors, and adolescent and pediatric cancers. Expertise includes standardized and individualized care, targeted therapy, cell therapy, and hematopoietic stem cell transplantation.
Dr. Li holds a postdoctoral degree and serves as an Associate Professor and master’s supervisor. Dr. Li has worked at the Institute of Hematology & Blood Diseases Hospital (CAMS), Washington University in St. Louis Cancer Center, and Beijing Children's Hospital, and visited Cincinnati Children's Hospital. Dr. Li was selected for the Beijing Outstanding Young Talent Program, leads national research projects, and has published over 20 academic articles.
Name order: in Chinese the family name comes first (Li Sidan). Papers usually list the name as Sidan Li or Li S.
Selected publications
13 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Innov, 2026 (senior author): Treatment Outcomes With Novel Targeted and Immunotherapeutic Regimens in CAYA Hodgkin Lymphoma: A Retrospective Study. PubMed 41978747
- Front Immunol, 2026 (senior author): Correction: New insights into the treatment of nasopharyngeal carcinoma in children, adolescents, and young adults: a retrospective study. PubMed 41884843
- Front Immunol, 2026 (senior author): New insights into the treatment of nasopharyngeal carcinoma in children, adolescents, and young adults: a retrospective study. PubMed 41884814
- Bone Marrow Transplant, 2024 (senior author): Successful use of defibrotide to treat allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy in pediatric patients: report from Chinese single center. PubMed 39043925
- Int J Med Sci, 2024 (senior author): Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research. PubMed 38774762
- Cancer Innov, 2023 (senior author): Advances in the treatment of solid tumors in children and adolescents. PubMed 38090056
- Pediatr Transplant, 2022 (senior author): Efficacy of hematopoietic stem cell transplantation in the treatment of children with non-severe aplastic anemia. PubMed 35735259
- Blood, 2022 (first author): IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function. PubMed 35675516
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion